CLINICAL CONSEQUENCES OF INFLIXIMAB IMMUNOGENICITY AND THE IMPACT OF THERAPEUTIC DRUG MONITORING: SECONDARY ANALYSES OF A RANDOMISED CLINICAL TRIAL.

Bibliographic Details
Title: CLINICAL CONSEQUENCES OF INFLIXIMAB IMMUNOGENICITY AND THE IMPACT OF THERAPEUTIC DRUG MONITORING: SECONDARY ANALYSES OF A RANDOMISED CLINICAL TRIAL.
Authors: Brun, M. K., Bjørlykke, K. H., Gehin, J. E., Warren, D. J., Klaasen, R. A., Sexton, J., Sandanger, Ø., Kvien, T. K., Mørk, C., Jahnsen, J., Bolstad, N., Jørgensen, K. K., Haavardsholm, E. A., Goll, G. L., Syversen, S. W.
Source: Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p40-40, 3/4p
Database: Complementary Index
More Details
ISSN:00034967
DOI:10.1136/annrheumdis-2023-eular.3054
Published in:Annals of the Rheumatic Diseases
Language:English